Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Financial Results Briefing for Q3 of FY2026 (April-December)
Notice of Revision of Earnings Forecast and Revision of Dividend Forecast (Dividend Increase)
Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending March 31, 2026 (Nine Months Ended December 31, 2025)
Acquisition of shares (subsidiarization) of a Thailand-based wellness-related company, Thann Oryza Co., Ltd.
Consolidated Financial Results for the Six Months Ended September 30, 2025
ROHTO Pharmaceutical Acquires OBAGI-Related Trademarks in Japan
Financial Results Briefing for 1stHalf of FY2026(April -September)
Notice of Revision of Earnings Forecast and Revision of Dividend Forecast (Dividend Increase)
Results of Operations for Q1 2025 (AprilăźJune)
Notice of Revision of Earnings Forecast
Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2026
Corporate Governance Report
Notice of Dividend of Surplus
Medium- to Long- Term Growth Strategy 2025-2035
ROHTO Pharmaceutical Co., Ltd. Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 Reference
Financial Results Briefing for the Fiscal Year Ending March 31, 2025
Rohto Group Medium- to Long-Term Growth Strategy 2025-2035
Consolidated Financial Results for the Year Ended March 31, 2025
Notice on Changes of President and Chief Operating Officer and Other Officers
Announcement of the Initiation of Domestic Phase II Clinical Trial for Heart Failure Treatment "ADR-002K"